Pavlovi et al. [28] demonstrated that plasma Gal-3 concentration was significantly higher in NSTEMI patients with preexisting AF than in those without preexisting AF, but Gal-3 was not significantly associated with composite outcomes. This evidence concerns the gene LGALS3 and atrial fibrillation.